Nurses Unlimited Inc Location: 3800 E 42nd Suite 203, Odessa, Texas 79762 Ratings: Phone: (432) 550-1700 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Star Care Home Health Inc Location: 620 N Grant Suite 100, Odessa, Texas 79761 Ratings: Phone: (432) 580-7707 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Express Nursing Location: 4700 University Blvd., Odessa, Texas 79762 Ratings: Phone: (432) 580-9393 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Home Nursing Location: 6010 E Hwy 191 Suite 235, Odessa, Texas 79762 Ratings: Phone: (432) 617-8125 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Nursex Home Health Services Llc Location: 2525 N Grandview Avenue Suite 600, Odessa, Texas 79761 Ratings: Phone: (432) 550-0268 Health Services: Nursing Care, Physical Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
News Archive
A leadless cardiac pacemaker showed "good safety and reliable function" during the initial six months of follow-up in the LEADLESS II study, investigators reported during a Hot Line presentation at the ESC congress 2015.
A clinical trial to find a better treatment for severe or chronic cases of post kala-azar dermal leishmaniasis (PKDL) in Africa has begun in Dooka, Sudan.
Single-disease initiatives in low-income countries with fragile health systems may compromise the ability of such health systems to meet the other community needs, according to a study published Tuesday in PLoS Neglected Tropical Diseases, VaccineNewsDaily.com reports (Purlain, 8/18).
Celgene International Sàrl announced that clinical data from two investigational studies evaluating the use of REVLIMID (lenalidomide) either with rituximab or following a rituximab-containing regimen in patients with chronic lymphocytic leukaemia were presented at the 52nd American Society of Hematology annual meeting.
› Verified 7 days ago